Abstract
Objective of this double-blind placebo-controlled study was to determine the efficacy of thermosensitive mucoadhesive gel loaded with 5-fluorouracil (5-FU):hydroxypropyl-ß-cyclodextrin (HP-ß-CD) complex via topical administration or intralesional injection for the treatment of human papilloma virus induced condyloma in 44 women. The diagnosis of human papilloma virus was established with clinical, histopathological and polymerase chain reaction techniques. Subjects were randomized into four parallel groups to evaluate topical or intralesional administration of drug-loaded or blank gel. The formulation used in the study consisted of 20% Pluronic PF 127 and 0.2% hydroxypropylmethylcellulose (HPMC) to render thermosensitive and mucoadhesive properties to the blank and drug-loaded gels. 5-FU was complexed to hydroxypropyl-ß-cyclodextrin to improve its solubility and this complex was loaded into thermosensitive gel to obtain controlled release of the cytotoxic drug in administration site over a two-week period cure regimen aiming therapeutic efficacy with lower 5-FU doses. Complete response was achieved in 61% of patients through intralesional administration while topical administration resulted in only 29% complete cure. Relapse rates of all therapy groups were significantly low in the 6-month follow-up time.
Similar content being viewed by others
References
Lacey, C.J.N.: Therapy for genital human papilloma virus related disease. J. Clin. Virol. 32S, S82–S90 (2005)
Parkin, D.M.: Cancer in developing countries. Cancer Surv. 19(20), 519–561 (1994)
Beutner, K.R., Ferenczy, A.: Therapeutic approaches to genital warts. Am. J. Med. 102, 28–37 (1997)
Baker, G.E., Tyring, S.K.: Therapeutic approaches to papilloma virus infections. Dermatol. Clin. 15, 331–340 (1997)
Gross, G.: Therapy of human papilloma virus infection and associated epithelial tumors. Intervirology 40, 368–377 (1997)
Syed, T.A., Qureshi, Z.A., Ahman, S.A., Ali, S.M.: Management of intravaginal warts in women with 5-fluorouracil (1%) in vaginal hydrophlic gel: a placebo-controlled double-blind study. Int. J. STD AIDS 11, 371–374 (2000)
Bilensoy, E., Çırpanlı, Y., Şen, M., Doğan, A.L., Çalış, S.: Thermosensitive mucoadhesive gel formulation loaded with 5-FU:cyclodextrin complex for HPV-induced cervical cancer. J. Incl. Phenom. Macrocycl. Chem. 57, 363–370 (2007)
Ceschel, G.C., Maffei, P., Lombardi Borgia, S., Ronchi, C., Rossi, S.: Development of a mucoadhesive dosage form for vaginal administration. Drug Dev. Ind. Pharm. 27(6), 541–547 (2001)
Hardy, E., Jimenes, A.L., de Padua, K.S., Zanewald, L.J.D.: Women’s peferences for vaginal antimicrobial contraceptives III Choice of a formulation, applicator and packaging. Contraception 58, 245–249 (1998)
Challa, R., Ahuja, A., Ali, J., Khar R.K.: Cyclodextrins in drug delivery. An updated review. AAPS Pharm. Sci. Tech. 6(2), Article #43 (2005)
Chang, J.Y., Oh, Y.K., Choi, H., Kim, Y.B., Kim, C.K.: Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int. J. Pharm. 241, 155–163 (2002)
Veyries, M.L., Couarrazze, G., Geiger, S., Agnely, F., Massias, L., Kunzli, B., Faurisson, R., Rouvex, B.: Controlled release of vancomycin from poloxamer 407 gels. Int. J. Pharm. 192, 183–193 (1999)
Krebs, H.B.: Treatment of vaginal condylomata acuminata by weekly topical application of 5-fluorouracil. Obstet. Gynecol. 70, 68–71 (1984)
Acknowledgement
Authors would like to acknowledge that this research project has been financially supported by Research Grant from Novartis, Turkey. Authors also would like to thank Dr. Christoph Winterhalter, Wacker Chemie for kindly supplying hydroxypropyl-ß-cyclodextrin.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bilensoy, E., Moroy, P., Çırpanlı, Y. et al. A double-blind placebo-controlled study of 5-fluorouracil:cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma. J Incl Phenom Macrocycl Chem 69, 309–313 (2011). https://doi.org/10.1007/s10847-010-9734-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-010-9734-3